Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 12/20 | 0.60 |
| ▸ | CES1 | P23141 | 11/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17122194 | 1.00 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL19932743 | 1.00 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL449946 | 0.82 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL1049892 | 0.82 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL28138711 | 0.82 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL108031 | 0.82 | CES2 (0.60) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL7808020 | 0.80 | CES2 (0.58) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL7808024 | 0.80 | CES2 (0.58) | CES2CES1MAPTRAB9AALDH1A1 | |
| SCHEMBL13069013 | 0.80 | CES2 (0.58) | CES2CES1MAPTRAB9AALDH1A1 | |
| Benzil SCHEMBL4814635 | 0.78 | CES2 (0.82) | CES2CES1MAPTRAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507725-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2013-08-13 | — | — | US | disclosed |
| US-20110170209-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110170209-A1 | OXIME ESTER PHOTOINITIATORS | RAD51, CBR3, CBR1 | CES2 214/4885CES1 160/4885MAPT 4380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.